-
11220-25A chemoselective probe for detecting sulfenylated proteins in intact cells using click chemistry.
-
11220-5A chemoselective probe for detecting sulfenylated proteins in intact cells using click chemistry.
-
14062-10A cell-permeable, reversible inhibitor of dynamin 1, dynamin 2, and mitochondrial dynamin, Drp1 GTPase activity (IC<sub>50</sub> = 15 &muM) inhibits clathrin-dependent vesicle formation and endocytosis can also augment the release of
-
14062-25A cell-permeable, reversible inhibitor of dynamin 1, dynamin 2, and mitochondrial dynamin, Drp1 GTPase activity (IC<sub>50</sub> = 15 &muM) inhibits clathrin-dependent vesicle formation and endocytosis can also augment the release of
-
14062-5A cell-permeable, reversible inhibitor of dynamin 1, dynamin 2, and mitochondrial dynamin, Drp1 GTPase activity (IC<sub>50</sub> = 15 &muM) inhibits clathrin-dependent vesicle formation and endocytosis can also augment the release of
-
14062-50A cell-permeable, reversible inhibitor of dynamin 1, dynamin 2, and mitochondrial dynamin, Drp1 GTPase activity (IC<sub>50</sub> = 15 &muM) inhibits clathrin-dependent vesicle formation and endocytosis can also augment the release of
-
18169-1A heptadecapeptide that acts as an endogenous opioid receptor agonist (Kis = 0.5-1 nM for &kappa, µ, and &delta) has been implicated in antinociceptive functions.
-
18169-10A heptadecapeptide that acts as an endogenous opioid receptor agonist (Kis = 0.5-1 nM for &kappa, µ, and &delta) has been implicated in antinociceptive functions.
-
18169-5A heptadecapeptide that acts as an endogenous opioid receptor agonist (Kis = 0.5-1 nM for &kappa, µ, and &delta) has been implicated in antinociceptive functions.
-
18169-500A heptadecapeptide that acts as an endogenous opioid receptor agonist (Kis = 0.5-1 nM for &kappa, µ, and &delta) has been implicated in antinociceptive functions.
-
18178-1A 13-residue opioid peptide that acts as an endogenous &kappa1b-opioid receptor agonist (Ki = 1.1 nM) has been implicated in antinociceptive functions and has also been used to prime cardiogenesis in pluripotent embryonic stem cells.
-
18178-10A 13-residue opioid peptide that acts as an endogenous &kappa1b-opioid receptor agonist (Ki = 1.1 nM) has been implicated in antinociceptive functions and has also been used to prime cardiogenesis in pluripotent embryonic stem cells.